Related Experiment Video

Updated: May 4, 2026

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library
07:32

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library

Published on: September 30, 2019

7.4K

Targeting the PDGF signaling pathway in tumor treatment

Carl-Henrik Heldin1

  • 1Ludwig Institute for Cancer Research, Science for life laboratory, Uppsala University, Box 595SE-751 24 Uppsala, Sweden. C-H.Heldin@LICR.uu.se.

Cell Communication and Signaling : CCS
|December 24, 2013
PubMed

Insights

Platelet-derived growth factor (PDGF) receptor signaling is crucial for cell growth and tissue repair. Inhibiting PDGF receptor signaling shows promise in treating rare tumors and is being studied for common cancers.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Platelet-derived growth factor (PDGF) and its receptors are vital for cell growth, survival, embryonal development, and tissue repair.
  • Aberrant PDGF receptor signaling, due to overexpression or mutations, can promote tumor cell proliferation.
  • PDGF receptors are expressed on tumor stromal cells like pericytes, fibroblasts, and myofibroblasts, contributing to tumorigenesis upon PDGF stimulation.

Purpose of the Study:

  • To review the role of PDGF receptor signaling in normal physiological processes and its implication in tumorigenesis.
  • To discuss the therapeutic potential of inhibiting PDGF receptor signaling in cancer treatment.

Main Methods:

  • Literature review of studies on PDGF and PDGF receptor functions.
  • Analysis of the role of PDGF receptor signaling in various cell types relevant to cancer.
  • Examination of clinical data on PDGF/PDGF receptor antagonist therapies.

Main Results:

  • PDGF signaling is essential for normal development and tissue repair.
  • Overactive PDGF receptor signaling is a driver in certain tumor types.
  • Inhibition of PDGF receptor signaling has demonstrated efficacy in treating rare tumors.

Conclusions:

  • PDGF receptor signaling plays a complex role in both normal cell function and cancer development.
  • Targeting PDGF receptor signaling is a validated therapeutic strategy for specific rare tumors.
  • Further research is warranted to explore the efficacy of PDGF/PDGF receptor antagonists in common malignancies.

More Related Videos

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles08:35

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

28.7K
Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

1.3K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K